| 11/16/2026 3:38 PM | Aspire Biopharma (1847345) Subject Rubenbauer Alois Ryan III (2142929) Filed by | Form SCHEDULE 13G/A | |
| 11/05/2026 11:28 AM | Aspire Biopharma (1847345) Subject Funk, Stephen P. (1626109) Filed by | Form SCHEDULE 13G | |
| 10/20/2026 4:31 PM | Aspire Biopharma (1847345) Filer | Form 8-K/A | |
| 09/29/2026 4:15 PM | Aspire Biopharma (1847345) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/09/2026 9:10 AM | Aspire Biopharma (1847345) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/08/2026 9:10 AM | Aspire Biopharma (1847345) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/19/2026 7:30 AM | Aspire Biopharma (1847345) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/14/2026 11:30 AM | Aspire Biopharma (1847345) Subject HIGHBRIDGE CAPITAL MANAGEMENT LLC (919185) Filed by | Form SCHEDULE 13G/A | |
| 08/13/2026 3:31 PM | Aspire Biopharma (1847345) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/10/2026 7:30 PM | Aspire Biopharma (1847345) Subject SHIRINYAN GARY (2149434) Filed by | Form SCHEDULE 13G | |
| 08/10/2026 8:45 AM | Aspire Biopharma (1847345) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for ASBP and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Aspire Biopharma and its competitors with MarketBeat's FREE daily newsletter.
|
| 08/06/2026 7:47 PM | Aspire Biopharma (1847345) Subject Friedman Lance (1470622) Filed by | Form SCHEDULE 13G/A | |
| 07/20/2026 4:20 PM | Aspire Biopharma (1847345) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/02/2026 7:38 AM | Aspire Biopharma (1847345) Subject Rubenbauer Alois Ryan III (2142929) Filed by | Form SCHEDULE 13G | |
| 06/22/2026 3:35 PM | Aspire Biopharma (1847345) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/12/2026 4:15 PM | Aspire Biopharma (1847345) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/12/2026 9:26 AM | Aspire Biopharma (1847345) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/15/2026 5:44 AM | Aspire Biopharma (1847345) Subject HIGHBRIDGE CAPITAL MANAGEMENT LLC (919185) Filed by | Form SCHEDULE 13G | |
| 05/14/2026 3:05 PM | Aspire Biopharma (1847345) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/13/2026 12:00 PM | ARDSLEY ADVISORY PARTNERS LP (900529) Filed by Aspire Biopharma (1847345) Subject | Form SCHEDULE 13G/A | |
| 05/12/2026 3:35 PM | Aspire Biopharma (1847345) Filer | Form DEFR14A | |
| 05/11/2026 7:34 AM | Aspire Biopharma (1847345) Filer | Form DEF 14A | |
| 04/28/2026 10:05 AM | Aspire Biopharma (1847345) Filer | Form PRE 14A | |
| 04/20/2026 8:00 AM | Aspire Biopharma (1847345) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/17/2026 5:10 AM | Aspire Biopharma (1847345) Filer | Form 8-K/A | |
| 04/16/2026 4:14 PM | Aspire Biopharma (1847345) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/16/2026 2:22 PM | Aspire Biopharma (1847345) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/16/2026 7:30 AM | Aspire Biopharma (1847345) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/15/2026 5:30 AM | Aspire Biopharma (1847345) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/14/2026 11:15 PM | Aspire Biopharma (1847345) Filer | Form EFFECT | |
| 04/10/2026 1:54 PM | Aspire Biopharma (1847345) Filer | Form S-1/A | |
| 04/08/2026 4:26 PM | Aspire Biopharma (1847345) Filer | Form 10-K/A | |
| 02/12/2026 4:29 PM | Aspire Biopharma (1847345) Filer | Form PRE 14A | |
| 02/12/2026 12:00 PM | ARDSLEY ADVISORY PARTNERS LP (900529) Filed by Aspire Biopharma (1847345) Subject | Form SCHEDULE 13G | |
| 02/12/2026 10:45 AM | Aspire Biopharma (1847345) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/06/2026 4:25 PM | Aspire Biopharma (1847345) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/15/2026 5:15 AM | Aspire Biopharma (1847345) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/13/2026 3:30 PM | Aspire Biopharma (1847345) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/06/2026 7:35 AM | Aspire Biopharma (1847345) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/14/2025 11:15 PM | Aspire Biopharma (1847345) Filer | Form EFFECT | |
| 12/02/2025 7:58 PM | Aspire Biopharma (1847345) Filer | Form S-1 Registration statement under Securities Act of 1933 | |
Why I'm selling my Snapback Indicator for just $7 (Ad) For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500.
The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long.
No strings attached, and Wood says there is an unusual reason behind the steep discount. Get lifetime access to the Snapback Indicator for a one-time $7 payment today. |